Close Menu

In Genome Biology this week, scientists led by those at EMBL in Heidelberg used what they call a "trans-regulation screen" to study the regulation of Ath5, the central node in the gene regulatory network controlling retinal ganglion cell differentiation in vertebrates. They were able to identify potential Ath5 regulators that they then validated in vivo by functional assays in medakafish embryos.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.